PubMed HealthSearch

PubMed · 2970693

Laser recanalization: a basic and clinical perspective.

Abstract

Inspite of the effectiveness of PTCA and surgery in the treatment of occlusive vascular diseases, still a number of patients remain untreatable by these methods. Laser light with its ability to ablate tissue and to be delivered even in small distal branches of the vascular tree seemed to offer a new perspective. The interaction between laser light and tissue is determined by special physical characteristics. Up till now none of the available laser systems are optimal for application in the cardiovascular system, but still many of them have been effective clinically. One common complication was the high perforation rate by the use of flexible quarz fibers which could not be visualized by fluoroscopy. The addition of a small metal ring and later-on of a metal cap covering the end of the fiber showed significant improvements. Not only could those fibers be visualized by a fluoroscopy, but could convert laser energy into thermal energy. The perforation rate was decreased and a greater size channel created. Lately the introduction of a small saphir window at the tip of the metal cap offered the combined application of light and thermal energy. Animal studies demonstrated these advantages with a low perforation and a high penetration rate of atherosclerotic material. Clinical studies also revealed good results and a significantly lower perforation rate with the metal capped probe. Using the probe with a small saphir window at its tip, the success rate in totally occluded peripheral vessels, not treatable by conventional PTCA, was 82%. As the newly created channel showed a sufficient diameter.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G S Abela. 1988. Laser recanalization: a basic and clinical perspective.. https://doi.org/10.1055/s-2007-1022989

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Pure beta-particle-emitting stents inhibit neointima formation in rabbits.

BACKGROUND: Considerable experimental evidence exists that neointimal hyperplasia after angioplasty is inhibited by gamma-irradiation of the treated arteries. A beta-particle radiation is absorbed in tissue within a shorter distance away from the source than gamma-radiation and may be more suitable for localized vessel irradiation. This study outlines a method to implant a beta-particle-emitting radioisotope (32P; half-life, 14.3 days) into metallic stents. The effects of these stents on the inhibition of neointimal hyperplasia was compared with conventional stents in a rabbit model. METHODS AND RESULTS: 32P was produced by irradiation of red amorphous phophorus (31P) with neutrons and was implanted into Palmaz-Schatz stents (7.5 mm in length) after being kept apart from 31P in a mass separator. The radioisotope was tightly fixed to the stents, and the ion implantation process did not alter the surface texture. Stent activity levels of 4 and 13 microCi were chosen for the study. Four and 12 weeks after placement of conventional stents and 32P-implanted stents in rabbit iliac arteries, vascular injury and neointima formation were studied by histomorphometry. Immunostaining for smooth muscle cell (SMC) alpha-actin was performed to determine SMC cellularity in the neointima. SMCs were quantified by computer-assisted counting of alpha-actin immunoreactive cells. Endothelialization of the stents was evaluated by immunostaining for endothelial cell von Willebrand factor. No difference in vessel wall injury was found after placement of conventional and 32P-implanted stents. Neointima formation was potently inhibited by 32P-implanted stents only at an activity level of 13 microCi after 4 and 12 weeks. Neointimal SMC cellularity was reduced in 32P-implanted stents compared with conventional stents. Radioactive stents were endothelialized after 4 weeks, but endothelialization was less dense than in conventional stents. CONCLUSIONS: Neointima formation in rabbits is markedly suppressed by a beta-particle-emitting stent incorporating the radioisotope 32P. In this model, a dose-response relation with this type of radioactive stent was observed, indicating that a threshold radiation dose must be delivered to inhibit neointima formation after stent placement over the long term.

Angioplasty, Balloon